The FARAVIEW™ System shown on a monitor and FARAWAVE™ NAV Pulsed Field Ablation Catheter next to it.

FARAVIEW™ in Practice: Clinical Insights from Your Peers

Discover the FARAVIEW Software Module through physicians’ insights.

Clinical Perspectives on FARAVIEW and Pulsed Field Ablation


Prof. Boveda shares how the PFA-integrated mapping system impacts his daily practice and offers his vision for the future of pulsed field ablation and emerging technologies in the field.


Hear Dr Gunawardene explain the clinical benefits of using a mapping system, and how FARAVIEW provides physicians with enhanced ability to visualise pulsed field ablations.

 

Dr Natale discusses the importance of mapping in PFA cases, highlighting the benefits of a dedicated 3D mapping system integrated with a PFA catheter for treating AF patients.


Watch Dr David DeLurgio and Dr Devi Nair explain the FARAVIEW Software Module, the challenges it addresses and their excitement for the mapping integration.

NAVIGATE-PF Trial 

The NAVIGATE-PF clinical trial was a multi-center, first-in-human feasibility study that assessed the acute and chronic accuracy of FIELDTAG™ Technology on the FARAVIEW™ Software Module in visualising pulsed field energy delivery by the FARAWAVE™ NAV Pulsed Field Ablation (PFA) Catheter. The study included two phases:

Phase I (acute assessment):

  • Phase 1 included 30 patients that underwent PV isolation, with 30% also receiving posterior wall ablation.
  • PFA markers were placed during PFA application and high-quality, post-ablation HD maps with INTELLAMAP ORION™ Mapping Catheter were completed in 15 pts. PFA markers were overlaid on the HD map and contours were drawn at the outer border of the low voltage areas (defined as ≤0.5mV) where at least 2 overlapping PFA markers were dropped.

Phase II (chronic assessment):

  • Included 20 patients at 1 center to evaluate chronic lesion durability and alignment between acute PFA tag locations and chronic low voltage borders.

Hear from Dr Bolao and Prof. Széplaki as they discuss the trial and their experiences with the FARAVIEW Software Module.

Dr Bolao highlights FARAVIEW’s advantages and the integration of FIELDTAG™ Technology.
 

University Clinic of Navarra (Pamplona, Spain)

Prof. Széplaki shares insights on the FARAWAVE NAV-enabled catheter and 3D mapping integration.
 

Mater Private Hospital (Dublin, Ireland)

 

CAUTION:
 The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material not intended for use in France.

Pending CE Mark